Corporate Earnings Increasingly Show Signs Of ‘Viagra’ Use
Reporting corporate earnings is becoming somewhat of a high-wire act where the tight-rope walker not only has to balance their way to the other side, but do so juggling five balls blindfolded. This circus side-show was on display last April when Boston Scientific Chief Financial Officer Dan Brennan, in one sitting, pulled out the word “adjusted” to describe the firm’s financial results on 34 separate occasions. That caveat was uttered from his mouth twice every minute on average, a recent . . .
SORRY!
This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here
If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible
